Cargando…

Progress in Medicinal Chemistry. volume 57 /

Progress in Medicinal Chemistry, Volume 57, provides a review of eclectic developments in medicinal chemistry, with this volume including chapters on the CaSR field, CFTR modulators in cystic fibrosis, macrocycles, VMAT2 inhibitors, and Big Data in Drug Discovery.

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Witty, D. R. (David R.) (Editor ), Cox, Brian (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cambridge, MA : Elsevier Ltd. : Elsevier, 2018.
Colección:Progress in Medicinal Chemistry ; Volume 57
Temas:
Acceso en línea:Texto completo
Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 SCIDIR_on1031373553
003 OCoLC
005 20231120010251.0
006 m o d
007 cr cnu|||unuuu
008 180416s2018 mau ob 000 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d N$T  |d OPELS  |d NLE  |d OPELS  |d OCLCF  |d CNCGM  |d UPM  |d D6H  |d OCLCQ  |d UKMGB  |d MUO  |d UKAHL  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO 
015 |a GBB857703  |2 bnb 
016 7 |a 018806572  |2 Uk 
020 |a 9780444641441  |q (electronic bk.) 
020 |a 0444641440  |q (electronic bk.) 
020 |z 9780128152133  |q (print ;  |q Part I) 
020 |z 0128152133  |q (print ;  |q Print I) 
035 |a (OCoLC)1031373553 
050 4 |a RS403 
072 7 |a MED  |x 071000  |2 bisacsh 
082 0 4 |a 615.19  |2 23 
245 0 0 |a Progress in Medicinal Chemistry.  |n volume 57 /  |c edited by David R. Witty and Brian Cox. 
264 1 |a Cambridge, MA :  |b Elsevier Ltd. :  |b Elsevier,  |c 2018. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 0 |a Progress in Medicinal Chemistry ;  |v Volume 57 
504 |a Includes bibliographical references. 
588 0 |a Online resource; title from PDF title page (EBSCO, viewed April 18, 2018). 
520 |a Progress in Medicinal Chemistry, Volume 57, provides a review of eclectic developments in medicinal chemistry, with this volume including chapters on the CaSR field, CFTR modulators in cystic fibrosis, macrocycles, VMAT2 inhibitors, and Big Data in Drug Discovery. 
505 0 |a Discovery and Development of Calcimimetic and Calcilytic Compounds -- VMAT2 Inhibitors and the Path to Ingrezza (Valbenazine) -- Current Trends in Macrocyclic Drug Discovery and beyond-Ro5 -- Recent Progress in the Discovery and Development of Small-Molecule Modulators of CFTR -- Big Data in Drug Discovery. 
650 0 |a Pharmaceutical chemistry. 
650 2 |a Chemistry, Pharmaceutical  |0 (DNLM)D002626 
650 6 |a Chimie pharmaceutique.  |0 (CaQQLa)201-0028674 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a Pharmaceutical chemistry  |2 fast  |0 (OCoLC)fst01060115 
700 1 |a Witty, D. R.  |q (David R.),  |e editor. 
700 1 |a Cox, Brian,  |e editor. 
776 0 8 |i Print version :  |z 9780128152133 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/bookseries/00796468/57/1  |z Texto completo 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/bookseries/00796468/57  |z Texto completo